Blockade of FASN leads to apoptosis in human breast cancer in vitro and in vivo [37] and FASN inhibition after epigallocatechin-3-gallate (EGCG) treatment induced apoptosis in breast cancer cells [36]. Here, FASN is linked to breast carcinoma.